L. Hughes

No Evidence for Production of Intrathecal Immunoglobulin G against Acinetobacter or Pseudomonas in Multiple Sclerosis

G. Giovannoni, E. Thompson, Clyde Wilson, 2004, European Neurology.

Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis.

A. Binder, A. Ebringer, T. Rashid, 2003, The Journal of rheumatology.

Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis

P. Smith, E. Thompson, S. Amor, 2003, Journal of Neuroimmunology.

Antibody Responses to Acinetobacterspp. and Pseudomonas aeruginosa in Multiple Sclerosis: Prospects for Diagnosis Using the Myelin-Acinetobacter-Neurofilament Antibody Index

E. Thompson, A. Ebringer, H. Tiwana, 2001, Clinical Diagnostic Laboratory Immunology.

Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker.

A. Ebringer, T. Rashid, Clyde Wilson, 2005, Archives of neurology.

Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy.

C. Ettelaie, A. Ebringer, C. Wilson, 2004, Veterinary immunology and immunopathology.

Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an ante-mortem test.

A. Ebringer, C. Wilson, S. Bansal, 2003, Journal of clinical & laboratory immunology.